Literature DB >> 27436577

Progressive development of renal cysts in glycogen storage disease type I.

Monika Gjorgjieva1,2,3, Margaux Raffin1,2,3, Adeline Duchampt1,2,3, Ariane Perry4, Anne Stefanutti1,2,3, Marie Brevet2,5, Antonin Tortereau2,6, Laurence Dubourg2,3,7,8, Aurélie Hubert-Buron4, Mylène Mabille9,10, Coralie Pelissou9,10, Louis Lassalle9,10, Philippe Labrune4,10, Gilles Mithieux1,2,3, Fabienne Rajas11,2,3.   

Abstract

Glycogen storage disease type I (GSDI) is a rare metabolic disease due to glucose-6 phosphatase deficiency, characterized by fasting hypoglycemia. Patients also develop chronic kidney disease whose mechanisms are poorly understood. To decipher the process, we generated mice with a kidney-specific knockout of glucose-6 phosphatase (K.G6pc-/- mice) that exhibited the first signs of GSDI nephropathy after 6 months of G6pc deletion. We studied the natural course of renal deterioration in K.G6pc-/- mice for 18 months and observed the progressive deterioration of renal functions characterized by early tubular dysfunction and a later destruction of the glomerular filtration barrier. After 15 months, K.G6pc-/- mice developed tubular-glomerular fibrosis and podocyte injury, leading to the development of cysts and renal failure. On the basis of these findings, we were able to detect the development of cysts in 7 out of 32 GSDI patients, who developed advanced renal impairment. Of these 7 patients, 3 developed renal failure. In addition, no renal cysts were detected in six patients who showed early renal impairment. In conclusion, renal pathology in GSDI is characterized by progressive tubular dysfunction and the development of polycystic kidneys that probably leads to the development of irreversible renal failure in the late stages. Systematic observations of cyst development by kidney imaging should improve the evaluation of the disease's progression, independently of biochemical markers.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27436577     DOI: 10.1093/hmg/ddw224

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  11 in total

Review 1.  Studies on glycogen storage disease type 1a animal models: a brief perspective.

Authors:  Irina O Petrova; Svetlana A Smirnikhina
Journal:  Transgenic Res       Date:  2022-08-25       Impact factor: 3.145

2.  Renal endoplasmic reticulum stress is coupled to impaired autophagy in a mouse model of GSD Ia.

Authors:  Benjamin L Farah; Dustin J Landau; Yajun Wu; Rohit A Sinha; Alwin Loh; Boon-Huat Bay; Dwight D Koeberl; Paul M Yen
Journal:  Mol Genet Metab       Date:  2017-09-01       Impact factor: 4.797

3.  Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.

Authors:  Elizabeth D Brooks; Dustin J Landau; Jeffrey I Everitt; Talmage T Brown; Kylie M Grady; Lauren Waskowicz; Cameron R Bass; John D'Angelo; Yohannes G Asfaw; Kyha Williams; Priya S Kishnani; Dwight D Koeberl
Journal:  J Inherit Metab Dis       Date:  2018-07-24       Impact factor: 4.982

Review 4.  Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia.

Authors:  Monika Gjorgjieva; Laure Monteillet; Julien Calderaro; Gilles Mithieux; Fabienne Rajas
Journal:  J Inherit Metab Dis       Date:  2018-06-04       Impact factor: 4.982

Review 5.  Glucose and glycogen in the diabetic kidney: Heroes or villains?

Authors:  Mitchell A Sullivan; Josephine M Forbes
Journal:  EBioMedicine       Date:  2019-08-10       Impact factor: 8.143

6.  Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.

Authors:  Ali Saeed; Joanne A Hoogerland; Hanna Wessel; Janette Heegsma; Terry G J Derks; Eveline van der Veer; Gilles Mithieux; Fabienne Rajas; Maaike H Oosterveer; Klaas Nico Faber
Journal:  Hum Mol Genet       Date:  2020-01-15       Impact factor: 6.150

7.  Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease.

Authors:  Luciana Hannibal; Jule Theimer; Victoria Wingert; Katharina Klotz; Iris Bierschenk; Roland Nitschke; Ute Spiekerkoetter; Sarah C Grünert
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-23       Impact factor: 5.555

8.  Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.

Authors:  Laure Monteillet; Monika Gjorgjieva; Marine Silva; Vincent Verzieux; Linda Imikirene; Adeline Duchampt; Hervé Guillou; Gilles Mithieux; Fabienne Rajas
Journal:  Mol Metab       Date:  2018-08-01       Impact factor: 7.422

9.  Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.

Authors:  Ariane Perry; Claire Douillard; Frederic Jonca; Francois Glowacki; Xavier Leroy; Paul Caveriviere; Aurélie Hubert; Philippe Labrune
Journal:  JIMD Rep       Date:  2020-01-29

10.  Estimated Renal Metabolomics at Reperfusion Predicts One-Year Kidney Graft Function.

Authors:  Thomas Verissimo; Anna Faivre; Sebastian Sgardello; Maarten Naesens; Sophie de Seigneux; Gilles Criton; David Legouis
Journal:  Metabolites       Date:  2022-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.